Published in J Lab Clin Med on September 01, 1976
Immune complexes in acute and chronic liver disease. Clin Exp Immunol (1978) 1.93
Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest (1978) 1.45
C3 metabolism in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 1.34
The immune response in hepatic cirrhosis: animal and human studies. Proc R Soc Med (1977) 1.23
Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. J Clin Invest (1990) 1.22
Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years. Clin Exp Immunol (1978) 1.07
Immune complexes and abnormal liver function in haemophilia. J Clin Pathol (1977) 0.99
Non-specificity of circulating immune complexes in patients with acute and chronic liver disease. Clin Exp Immunol (1980) 0.91
Complement activation in chronic liver disease. Clin Exp Immunol (1982) 0.86
Increased C1q binding and arthritis in primary biliary cirrhosis. Gut (1980) 0.83
The in-vivo metabolism of C3 in ankylosing spondylitis. Ann Rheum Dis (1982) 0.80
Primary biliary cirrhosis. Br Med J (Clin Res Ed) (1982) 0.75
Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet (1977) 3.43
Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther (2014) 3.39
Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology (1996) 2.99
The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J Clin Invest (1972) 2.88
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med (1986) 2.85
Itch: scratching more than the surface. QJM (2003) 2.75
Cholangiography in the jaundiced patient. Gut (1976) 2.44
Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics (2000) 2.40
The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin. Tissue Antigens (1978) 2.40
The beta2-microglobulin gene is on chromosome 15 and not in the HL-A region. Nature (1975) 2.29
A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology (1976) 2.25
Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J Immunol (1998) 2.18
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut (2000) 2.16
Is primary biliary cirrhosis an immune complex disease? Lancet (1977) 2.15
Serum trypsin concentrations in diabetes mellitus. Br Med J (1978) 2.09
Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ (1996) 2.04
Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 2.04
Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med (1981) 1.96
Systematic review: hepatitis-associated aplastic anaemia--a syndrome associated with abnormal immunological function. Aliment Pharmacol Ther (2009) 1.83
Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM (1996) 1.81
Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut (1999) 1.80
The role of cell-surface receptors in the transport and catabolism of immunoglobulins. Ciba Found Symp (1972) 1.80
Acute polymyositis in an adult associated with Mycoplasma pneumoniae infection. Postgrad Med J (1990) 1.80
The slowing of gastric emptying by monosaccharides and disaccharides in test meals. J Physiol (1968) 1.79
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
Neurological complications following liver transplantation. Lancet (1987) 1.76
Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology (1988) 1.74
Wilson's disease with superimposed autoimmune features: report of two cases and review. J Gastroenterol Hepatol (2000) 1.70
Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med (1982) 1.67
Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut (1984) 1.66
Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut (1997) 1.66
The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology (1975) 1.66
Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors. Br J Cancer (2000) 1.66
Clinical heterogeneity associated with deletions in the long arm of chromosome 15: report of 3 new cases and their possible genetic significance. Am J Med Genet (1987) 1.62
Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med (1991) 1.59
Radiological intervention in Budd-Chiari syndrome: techniques and outcome in 18 patients. Clin Radiol (1996) 1.57
Immune-complex mediated colitis in rabbits. An experimental model. Gut (1978) 1.54
Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis. J Hepatol (1995) 1.54
The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med (1979) 1.54
Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet (1994) 1.53
Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest (1983) 1.52
Chronic pancreatitis: a cause of cholestasis. Gut (1977) 1.51
Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest (1978) 1.45
Pancreatic cholera due to production of gastric inhibitory polypeptide. Lancet (1972) 1.44
Enhanced (cytomegalovirus) viral replication after transplantation for fulminant hepatic failure. Liver Transpl Surg (1997) 1.44
Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol (1999) 1.43
Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol (1998) 1.43
Genetics and serology of HL-A-linked human Ia antigens. Cold Spring Harb Symp Quant Biol (1977) 1.42
Association of spinocerebellar disorders with cystic fibrosis or chronic childhood cholestasis and very low serum vitamin E. Lancet (1981) 1.40
Colonic Crohn's disease and use of oral contraception. Br Med J (Clin Res Ed) (1984) 1.40
Successful pregnancy in a patient with type III glycogen storage disease managed with cornstarch supplements. Br J Obstet Gynaecol (1998) 1.40
Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet (2000) 1.39
Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. Gastroenterology (1980) 1.36
NIH conference: Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med (1983) 1.35
C3 metabolism in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 1.34
Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. Proc Natl Acad Sci U S A (1988) 1.34
Primary hepatic malignancy: the role of liver transplantation. Br J Surg (1990) 1.34
Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med (1987) 1.33
Hepatic coma due to acute hepatic necrosis treated by exchange blood-transfusion. Lancet (1967) 1.30
GSTM1 null polymorphism at the glutathione S-transferase M1 locus: phenotype and genotype studies in patients with primary biliary cirrhosis. Gut (1993) 1.30
Comparing the anatomical consistency of the posterior superior iliac spine to the iliac crest as reference landmarks for the lumbopelvic spine: a retrospective radiological study. Clin Anat (2007) 1.29
Pharmacological thrombolysis in Budd Chiari syndrome: a single centre experience and review of the literature. J Hepatol (2004) 1.28
Isolation, structure and genetics of HLA-A, -B, -C and -DRw (Ia) antigens. Br Med Bull (1978) 1.27
Biopsy findings in cases of rejection of liver allograft. J Clin Pathol (1985) 1.24
Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis. Eur J Gastroenterol Hepatol (1997) 1.24
The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat. Transplantation (1992) 1.23
Endoscopic retrograde cholangiopancreatography in the diagnosis of jaundice associated with ulcerative colitis. Gastroenterology (1974) 1.22
Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis. N Engl J Med (1979) 1.22
Role of plasma membrane ligand-binding proteins in the hepatocellular uptake of albumin-bound organic anions. Hepatology (1987) 1.21
Protein metabolism in the intestinal stagnant loop syndrome. Gut (1968) 1.21
Meiotic maturation in Xenopus oocytes: a link between the cessation of protein secretion and the polarized disappearance of Golgi apparati. J Cell Biol (1985) 1.20
Development of the Xenopus pronephric system. Dev Biol (1995) 1.20
Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology (1990) 1.19
Massive infection with Fasciola hepatica in man. Am J Med (1977) 1.19
Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci (1999) 1.19
Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing. J Med Genet (2009) 1.18
Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features. QJM (2000) 1.18
Biliary secretion in a patient with cystic dilation of the intrahepatic biliary tree. Gastroenterology (1968) 1.18
Sclerosing cholangitis associated with multifocal fibrosis: a case report. Gut (1992) 1.17
High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. J Hepatol (1999) 1.17
Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol (1988) 1.16
Bacteraemia in association with hepatocellular and hepatobiliary disease. Postgrad Med J (1967) 1.16
Recurrence of autoimmune hepatitis after liver transplantation. Transplantation (1999) 1.16
Serum complement in chronic liver disease. Gut (1973) 1.15
Foetal brain development in the sheep. Neuropathol Appl Neurobiol (1979) 1.15
Transforming growth factor-beta induces human T lymphocyte migration in vitro. J Immunol (1991) 1.15
Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study. J Hepatol (1998) 1.14
The uptake of native and desialylated glucocerebrosidase by rat hepatocytes and Kupffer cells. Biochem Biophys Res Commun (1978) 1.14
Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. Gastroenterology (1984) 1.14
A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. Ann Intern Med (1986) 1.14
Studies on the particulate lactose synthetase of mouse mammary gland and the role of -lactalbumin in the initiation of lactose synthesis. Biochem J (1972) 1.13
Phalloidin-induced cholestasis: a microfilament-mediated change in junctional complex permeability. Proc Natl Acad Sci U S A (1980) 1.13
A model of fulminant hepatic failure in the rabbit. Gastroenterology (1978) 1.12
Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology (1992) 1.12
Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology (1985) 1.11
The iodine deficiency disorders: nature, pathogenesis and epidemiology. World Rev Nutr Diet (1990) 1.11
Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. J Clin Invest (1988) 1.11